PHAT vs GILD: Which Stock is Better?
Side-by-side comparison of Phathom Pharmaceuticals Inc and Gilead Sciences Inc in 2026
PHAT
Phathom Pharmaceuticals Inc
—
GILD
Gilead Sciences Inc
$135.64
Key Metrics Comparison
| Metric | PHAT | GILD | Winner |
|---|---|---|---|
| Market Cap | $622.74M | $160.15B | GILD |
| P/E Ratio | N/A | 17.55 | GILD |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PHAT
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHAT or GILD a better investment?
Comparing PHAT and GILD: Phathom Pharmaceuticals Inc has a market cap of $622.74M while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHAT and GILD?
PHAT (Phathom Pharmaceuticals Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHAT or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHAT or GILD?
Both PHAT and GILD show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PHAT or GILD?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PHAT or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $622.74M for PHAT.
Should I buy PHAT or GILD in 2026?
Both PHAT and GILD have investment merit. PHAT trades at $N/A while GILD trades at $135.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHAT and GILD stock?
Key differences: Market Cap ($622.74M vs $160.15B), P/E Ratio (N/A vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PHAT or GILD in 2026?
The choice between PHAT and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PHAT and GILD?
PHAT (Phathom Pharmaceuticals Inc) has a market cap of $622.74M, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.